Ads by Google
Flu and Cold
Rhode Island Is Number One In Adult Flu Shots
Rhode Island had the nation's highest rate in 2007 for influenza vaccination among adults 65 years and older
Experts Review Influenza Pandemic Preparedness Guidance
With the onging threat of a global influenza pandemic demanding continued vigilance health officials around the globe are meeting in Geneva to review the current WHO pandemic preparedness guidance.
Confirmed H7N7 Avian Influenza In Oxfordshire Poultry Farm
Following confirmation of the avian influenza virus subtype as H7N7, the Health Protection Agency has reviewed actions taken in the Oxfordshire poultry farm outbreak.
Quick Way To Make Human Monoclonal Antibodies Against Flu
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single cell - against influenza can be rapidly produced in the lab.
GlaxoSmithKline Comes Up With Approved Flu Vaccine
GlaxoSmithKline announced the approval by European regulators on its new flu vaccine.
The Deadly Intersection of the Flu and MRSA
ABC News and the Boston Globe have run reports highlighting the potential threat of co-infection of influenza and MRSA.
This Year's Flu Vaccine Predictions Failed
A report by CDC showed that this year's flu vaccine was not effective enough, because vaccine predictions failed.
Understanding Forces Behind Seasonal Flu Virus Evolution
Do influenza viruses persist in low levels year-round in the northern and southern hemispheres, or does a new crop of the virus emerge afresh in tropical zones such as Southeast Asia before spreading into temperate regions around the globe?
Novavax's Seasonal Influenza Vaccine Candidate Is Successful In Study
Novavax has received positive results from an immunogenicity study in ferrets inoculated with the company's trivalent seasonal influenza vaccine candidate. These findings will enable Novavax to complete its planned investigational new drug (IND) application to support initiation of a Phase II clinical trial targeted to begin in the third quarter of this year.